Regulatory Actions

Alma Lasers Receives FDA Clearance for the Accent Dual Mode RF System

Published in Medical Letter on the CDC and FDA, May 20th, 2007

Alma Lasers, a global leader in laser, light-based and radio frequency (RF) technologies used in aesthetic medicine, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market the Accent(TM) Dual Mode RF System in the United States.

Receiving its first FDA indication for the treatment of wrinkles and rhytids, the Accent system has been used successfully by medical professionals worldwide to treat a variety of dermatological and aesthetic conditions.

"We're delighted to receive the marketing clearance for the Accent product in the United States," stated Howard Kelly, CEO for Alma Lasers. "The unique dual mode...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2007-05-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry